Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Numerai GP LLC

Numerai GP LLC decreased its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 34.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,739 shares of the company’s stock after selling 9,759 shares during the period. Numerai GP LLC’s holdings in Ryan Specialty were worth $1,202,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Mariner LLC boosted its position in Ryan Specialty by 3.4% during the fourth quarter. Mariner LLC now owns 5,278 shares of the company’s stock worth $339,000 after acquiring an additional 172 shares during the last quarter. Sanctuary Advisors LLC lifted its holdings in shares of Ryan Specialty by 1.2% during the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock worth $1,045,000 after acquiring an additional 188 shares during the period. State of Alaska Department of Revenue boosted its position in shares of Ryan Specialty by 1.6% in the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock worth $778,000 after acquiring an additional 190 shares during the last quarter. CIBC Asset Management Inc increased its position in Ryan Specialty by 5.6% during the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock worth $236,000 after purchasing an additional 196 shares during the last quarter. Finally, Treasurer of the State of North Carolina boosted its holdings in shares of Ryan Specialty by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 44,990 shares of the company’s stock valued at $2,887,000 after purchasing an additional 280 shares during the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Ryan Specialty Trading Down 1.4%

Shares of NYSE:RYAN opened at $68.14 on Wednesday. Ryan Specialty Holdings, Inc. has a fifty-two week low of $52.34 and a fifty-two week high of $77.16. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market cap of $17.85 billion, a PE ratio of 98.76, a P/E/G ratio of 1.19 and a beta of 0.68. The company’s 50-day moving average price is $70.11 and its 200 day moving average price is $68.72.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting the consensus estimate of $0.39. The firm had revenue of $690.17 million for the quarter, compared to analysts’ expectations of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm’s quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.35 earnings per share. Sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a $0.48 annualized dividend and a dividend yield of 0.70%. Ryan Specialty’s dividend payout ratio (DPR) is 141.18%.

Insider Activity

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

RYAN has been the topic of a number of research reports. Royal Bank of Canada cut their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday, February 21st. UBS Group boosted their price objective on Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. Keefe, Bruyette & Woods dropped their target price on Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating on the stock in a report on Wednesday, April 9th. The Goldman Sachs Group upgraded shares of Ryan Specialty from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $74.00 to $81.00 in a research note on Tuesday. Finally, Barclays lowered their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating for the company in a report on Friday, April 11th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $76.42.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.